UA81573C2 - Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients - Google Patents

Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients

Info

Publication number
UA81573C2
UA81573C2 UAA200609697A UAA200609697A UA81573C2 UA 81573 C2 UA81573 C2 UA 81573C2 UA A200609697 A UAA200609697 A UA A200609697A UA A200609697 A UAA200609697 A UA A200609697A UA 81573 C2 UA81573 C2 UA 81573C2
Authority
UA
Ukraine
Prior art keywords
agomelatine
sleep disorders
medicaments
preparation
treatment
Prior art date
Application number
UAA200609697A
Other languages
English (en)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36200255&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81573(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UA81573C2 publication Critical patent/UA81573C2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
UAA200609697A 2005-09-09 2006-09-08 Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients UA81573C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509207A FR2890562B1 (fr) 2005-09-09 2005-09-09 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime

Publications (1)

Publication Number Publication Date
UA81573C2 true UA81573C2 (en) 2008-01-10

Family

ID=36200255

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609697A UA81573C2 (en) 2005-09-09 2006-09-08 Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients

Country Status (26)

Country Link
US (1) US20070060655A1 (xx)
EP (2) EP1762237A1 (xx)
JP (1) JP2007077148A (xx)
KR (2) KR20070029608A (xx)
CN (1) CN1927193B (xx)
AP (1) AP2008004379A0 (xx)
AR (1) AR056063A1 (xx)
AU (1) AU2006209372A1 (xx)
BR (1) BRPI0603762A (xx)
CA (1) CA2558762A1 (xx)
EA (1) EA014288B1 (xx)
FR (1) FR2890562B1 (xx)
GE (1) GEP20094602B (xx)
GT (1) GT200600409A (xx)
HK (1) HK1100481A1 (xx)
MA (1) MA28506B1 (xx)
MX (1) MXPA06010233A (xx)
NO (1) NO20064050L (xx)
NZ (1) NZ549726A (xx)
PE (1) PE20070333A1 (xx)
SG (1) SG146451A1 (xx)
TW (1) TW200800148A (xx)
UA (1) UA81573C2 (xx)
UY (1) UY29777A1 (xx)
WO (1) WO2007028905A1 (xx)
ZA (1) ZA200607531B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918370B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2918372B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2013119605A1 (en) * 2012-02-07 2013-08-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Promoting sleep using at1 receptor blockers
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
PT2810656T (pt) 2013-06-06 2017-11-13 Zentiva As Formulações de agomelatina compreendendo agomelatina na forma de cocristais
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
EP2856934A1 (en) * 2013-10-04 2015-04-08 Les Laboratoires Servier Biomarkers for the prediction of long term remission in depression
CN103690499B (zh) * 2013-12-23 2015-05-06 天津泰普药品科技发展有限公司 一种稳定的晶i型阿戈美拉汀片剂及其制备方法
CN103655499B (zh) * 2013-12-23 2015-07-22 天津泰普药品科技发展有限公司 一种稳定的晶x型阿戈美拉汀片剂及其制备方法
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2007517040A (ja) * 2003-12-24 2007-06-28 セプレイコー インコーポレイテッド 睡眠の質を改善するためのメラトニン併用療法
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7645905B2 (en) * 2005-08-03 2010-01-12 Les Laboratoires Servier Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
FR2890562A1 (fr) 2007-03-16
KR20070029608A (ko) 2007-03-14
NZ549726A (en) 2008-03-28
SG146451A1 (en) 2008-10-30
KR20080103043A (ko) 2008-11-26
EP2295050A1 (fr) 2011-03-16
GEP20094602B (en) 2009-02-10
GT200600409A (es) 2007-04-30
WO2007028905A1 (fr) 2007-03-15
AU2006209372A1 (en) 2007-03-29
JP2007077148A (ja) 2007-03-29
FR2890562B1 (fr) 2012-10-12
NO20064050L (no) 2007-03-12
EA014288B1 (ru) 2010-10-29
PE20070333A1 (es) 2007-06-02
CN1927193A (zh) 2007-03-14
MA28506B1 (fr) 2007-04-03
TW200800148A (en) 2008-01-01
HK1100481A1 (en) 2007-09-21
BRPI0603762A (pt) 2007-05-15
CA2558762A1 (fr) 2007-03-09
AP2008004379A0 (en) 2008-04-30
CN1927193B (zh) 2011-01-05
AR056063A1 (es) 2007-09-19
EA200601449A1 (ru) 2007-04-27
UY29777A1 (es) 2006-10-31
MXPA06010233A (es) 2007-03-08
EP1762237A1 (fr) 2007-03-14
US20070060655A1 (en) 2007-03-15
ZA200607531B (en) 2008-05-28

Similar Documents

Publication Publication Date Title
UA81573C2 (en) Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
CL2008003363A1 (es) Uso de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina y sus sales farmaceuticamente aceptables para tratar depresion severa, ansiedad, abuso o dolor cronico, en pacientes que han recibido medicacion con anterioridad y que han abandonado o reducido a eventos adversos relacionados con el sueño o la actividad sexual.
MX2011013902A (es) Tratamiento de esclerosis multiple con laquinimod.
SG166820A1 (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
IL198184A0 (en) Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue
GB0620385D0 (en) Novel compounds
EA200700574A3 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства
HK1126689A1 (en) Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders
SE0400184D0 (sv) New therapeutical use
MX2008002456A (es) Uso de ambroxol para el tratamiento de infecciones por rinovirus.
GEP20094651B (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
MY145925A (en) Use of agomelatine to obtain medication aimed at treating periventricular leukomalacia
WO2009025091A1 (ja) 線維筋痛症治療用医薬組成物
SI1824472T1 (sl) Uporaba acetil-l-karnitina za zdravljenje fibromialgiäśnega sindroma
PL356378A1 (en) Medicinal product for metal therapy to be attached to skin, foot cover, sock and elastic bandage
TH85141B (th) สารสำหรับป้องกันหรือรักษาความผิดปกติของการนอน